Free Trial

Cronos Group (CRON) Stock Forecast & Price Target

$2.37
-0.12 (-4.82%)
(As of 07/24/2024 ET)

Cronos Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 2 Wall Street analysts who have issued ratings for Cronos Group in the last 12 months, the stock has a consensus rating of "Hold." Out of the 2 analysts, 1 has given a sell rating, and 1 has given a buy rating for CRON.

Consensus Price Target

$3.00
26.58% Upside
High Forecast$3.50
Average Forecast$3.00
Low Forecast$2.50

According to the 2 analysts' twelve-month price targets for Cronos Group, the average price target is $3.00. The highest price target for CRON is $3.50, while the lowest price target for CRON is $2.50. The average price target represents a forecasted upside of 26.58% from the current price of $2.37.

TypeCurrent Forecast
7/26/23 to 7/25/24
1 Month Ago
6/26/23 to 6/25/24
3 Months Ago
4/27/23 to 4/26/24
1 Year Ago
7/26/22 to 7/26/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$3.00$3.00$2.83$3.00
Forecasted Upside26.58% Upside16.00% Upside26.71% Upside17.34% Upside
Get Cronos Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

CRON Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRON Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cronos Group Stock vs. The Competition

TypeCronos GroupMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.72
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside26.58% Upside3,260.86% Upside10.62% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/15/2024CIBC
3 of 5 stars
 Boost TargetOutperformer ➝ Outperformer$3.00 ➝ $3.50+19.05%
4/8/2024Bank of America
4 of 5 stars
 Boost TargetUnderperform ➝ Underperform$2.00 ➝ $2.50-6.72%
5/18/2023Roth Capital
4 of 5 stars
W. Kirk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
5/15/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$3.50 ➝ $3.00+73.41%
3/1/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$7.00 ➝ $3.00+42.18%
11/8/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matt Bottomley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetC$5.00 ➝ C$4.75
11/1/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$3.00-7.12%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:26 AM ET.

CRON Forecast - Frequently Asked Questions

What is Cronos Group's forecast for 2024?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Cronos Group is $3.00, with a high forecast of $3.50 and a low forecast of $2.50.

Should I buy or sell Cronos Group stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There is currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" CRON shares.

Does Cronos Group's stock price have much upside?

According to analysts, Cronos Group's stock has a predicted upside of 16.00% based on their 12-month stock forecasts.

What analysts cover Cronos Group?

Cronos Group has been rated by research analysts at CIBC in the past 90 days.

Do Wall Street analysts like Cronos Group more than its competitors?

Analysts like Cronos Group less than other "medical" companies. The consensus rating for Cronos Group is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CRON compares to other companies.


This page (NASDAQ:CRON) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners